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330a Monday, February 27, 2012Our data suggest that re-assessment of mechanisms underlying hERG activa-
tion gating is required, particularly with regard to the coupling mechanisms be-
tween voltage sensor movement and channel pore opening.
1 Es-Salah-Lamoureux et al., 2010, PLoS One 28;5(5):e10876
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Reduction of the current carried by the cardiac potassium channel HERG can
lead to Long QT syndrome, an arrhythmia characterized by a rapid heart rate
and reduced cardiac output, which can, in certain situations, be fatal. The effect
of extracellular electrolytes on the biophysical properties of the HERG channel
have been studied in some detail. In particular, increases in extracellular cal-
cium, magnesium and hydrogen have been shown to slow channel deactivation.
In addition, a number of reports have also shown that hydrogen can reduce
HERG current by a mechanism that does not involve an effect on channel de-
activation and which may involve pore block. We show here that reducing ex-
tracellular potassium results in a significant increase in HERG current
reduction by both extracellular calcium and hydrogen. The Drosophila
voltage-gated potassium channel Shaker, showed a much smaller decrease in
current by extracellular calcium and this effect was not dependent on extracel-
lular potassium. Furthermore, the reduction in HERG current by extracellular
hydrogen depended on the extracellular calcium concentration. Taken together
these results suggest that calcium and hydrogen can block the HERG potassium
channel and that calcium, hydrogen, and potassium may interact at the outer
pore of the HERG channel. These extracellular electrolyte effects may be spe-
cific to the HERG channel.
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Drug-induced prolongation of the QT interval via hERG block is a major cause
of attrition in drug development. The advent of automated electrophysiology
systems has greatly reduced this risk by enabling the detection of hERG block
earlier in drug discovery. In this study, we have evaluated the suitability of the
IonWorks Barracuda for the characterization of hERG biophysics and pharma-
cology. The IonWorks Barracuda is a second generation automated patch
clamp system with increased throughput and capabilities, allowing 384 parallel
recordings and up to 8 additions per recording. All experiments were conducted
with CHO cells stably expressing hERG. Recordings were made in population
patch clamp mode, where each current is measured from an average of up to 64
cells. We first examined hERG gating characteristics. HERG V1/2 for activa-
tion was7.85 1.8 mV (n=183) on the IonWorks Barracuda versus 17.55
5.3 mV (n=9) by manual patch clamp. For pharmacological experiments, all
drug additions were made in a cumulative fashion such that up to 384 dose-
responses could be obtained in a single experiment. Seal resistances and cur-
rents were stable (<20% change) with up to 6 additions and 1-minute incuba-
tions per addition. Over 27 experiments, 96% of the recordings yielded full
dose-response curves. HERG pharmacology was examined with a set of 353
compounds that included well-characterized hERG blockers. Astemizole, terfe-
nadine and quinidine inhibited hERG currents with IC50 values of 159 nM, 224
nM and 2 microM, respectively (n=51, 10 & 18). This set of compounds was
also tested with the PatchXpress automated electrophysiology system. We de-
termined through statistical methods that the two automated systems provided
equivalent results. In conclusion, this study showed that hERG biophysical and
pharmacological characterizations can be conducted very efficiently with the
IonWorks Barracuda.
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The voltage-gated ether-a-go-go (EAG) potassium channel family plays an im-
portant role in cardiac and neuronal repolarization, tumor proliferation and hor-
mone secretion. These channels are tetrameric, with six transmembrane helicesper subunit and large N- and C-terminal cytoplasmic domains. The function of
the cytoplasmic domains remains unclear, but it is thought that they are in-
volved in channel regulation since they can be phosphorylated and can interact
with kinases, integrins and calmodulin. In particular, the C-terminal domain has
strong homology to cyclic nucleotide binding domains (CNBDs) but it has been
demonstrated that EAG channel function is not affected by cyclic nucleotides
and that the domain does not bind nucleotides, in vitro. I have determined the
2.2 A˚ X-ray structure of one of these domains from the mouse EAG1 channel;
the structure has the canonical CNBD fold but it shows a ligand pocket that has
several differences relative to a cyclic nucleotide binding site, shedding some
light into why these domains are not able to bind cyclic nucleotides. Here I
present the biochemical characterization of this domain, a first step in the un-
derstanding the role of the C-terminal cytoplasmic domain in channel
regulation.
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Hyperpolarization-activated cyclic nucleotide-regulated (HCN) channels are
pace-making channels that contribute to rhythmic activity in the heart and
brain. All HCN-family channels contain a large intracellular domain in their
carboxy terminal region which includes a cyclic nucleotide binding domain
(CNBD) and a C-linker that connects it to the pore. We recently reported
that the flavonoids luteolin and myricetin regulate Eag1 channels by binding
a domain in their carboxy-terminal region that shares sequence and structural
similarity with the CNBD of HCN2. In a screen of flavonoids, we identified
fisetin as another potent regulator of Eag1. Fisetin shifted the voltage-
dependence of Eag1 channels toward more hyperpolarizing potentials and
slowed channel deactivation. Here we demonstrate that fisetin also regulates
the kinetic and steady state properties of HCN2 channels. We found that
30 mM fisetin sped activation at 140 mV, decreasing the time constant
from 1.17 5 0.10 s to 0.80 5 0.8 s (N=10). Additionally, 30 mM fisetin
shifted the Vhalf of the conductance-voltage relationship from 127.8 5
0.7 mV, to 120.4 5 0.7 mV (N=10). Fisetin shifted the voltage-
dependence of Eag and HCN channels in opposite directions, indicating that
it is not simply interacting with the voltage sensor. Furthermore we found
that fisetin and cAMP had non-additive effects on HCN2 channel gating. Us-
ing a FRET-based binding assay, we showed that fisetin bound to the purified
CNBD of HCN2. Additionally, fisetin did not speed activation or shift the
voltage-dependence of HCN2 channels lacking their CNBD. Together these
data indicate that the CNBD mediates fisetin regulation of HCN2 channels.
Based on the similar regulation of Eag and HCN channels by fisetin we pro-
pose that the mechanisms underlying ligand-mediated gating is well-
conserved amongst these channels.
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The Human Ether-a´-go-go Related Gene (hERG) encodes a voltage-activated
Kþ channel. hERG contributes to the repolarization of the ventricular action
potential as part of the IKr current and has also been shown to modulate neuro-
nal firing frequency. hERG gating is characterized by rapid inactivation upon
depolarization and rapid recovery from inactivation and slow closing (deactiva-
tion) upon repolarization. These factors combine to create a resurgent hERG
current, where the current amplitude is paradoxically larger with repolarization
than with depolarization. Previous data have shown that the N-terminal region
of hERG regulates gating kinetics, however the molecular mechanisms of this
regulation are not fully understood. Deletion of the hERG N-terminus (amino
acids 2-354) has been shown to speed channel deactivation and recovery from
inactivation compared to that of wild-type hERG channels. Relative outward
current amplitude is also increased during the depolarization phase, leading
to reduced current rectification. A genetically encoded eag domain fragment
(amino acids 1-135) was shown to restore slow deactivation to N-truncated
channels by forming a stable interaction with the C-terminal cyclic nucleotide
binding domain (CNBD). Our present study sought to further investigate the
contributions of the eag domain and proximal N-terminal region (amino acids
136-354) to hERG gating kinetics. We coexpressed genetically encoded N-ter-
minal region fragments with hERG channels bearing a deletion of the full
N-terminus (D2-354) or the eag domain (D2-135) in Xenopus oocytes and mea-
sured current with two-electrode voltage-clamp recordings. Here we report that
Monday, February 27, 2012 331aeag domain-containing fragments (N1-135, N1-354) were demonstrated to re-
duce relative outward current, slow deactivation, and slow recovery from inac-
tivation, resulting in channels with properties similar to those measured in wild-
type hERG. The proximal N-terminal region was shown to be involved in
steady-state activation.
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KCNQ1 and hERG encode the voltage-gated Kþ channel a-subunits of the car-
diac repolarizing currents IKs and IKr, respectively. These currents function
in vivo with some redundancy to maintain appropriate action potential dura-
tions (APDs), following the concept of repolarization reserve, and mutations
can manifest clinically as long QT syndrome, arrhythmia, and sudden cardiac
death. Previous work in transgenic rabbit cardiomyocytes and heterologous
cells demonstrated functional downregulation of complementary repolarizing
currents due to direct interactions between hERG and KCNQ1 a-subunits,
which may involve the hERG cyclic nucleotide binding domain (CNBD).
We hypothesize that direct interactions between KCNQ1 and hERG are medi-
ated by their C-termini and are dynamically regulated by physiological stimuli,
specifically intracellular cAMP levels. We created ion channel fusions to GFP
variants, which have been characterized by cellular electrophysiology and fluo-
rescent imaging. Acceptor photobleach FRET (apFRET) was employed in fixed
cells to quantitatively assess the extent of interactions based on fluorophore lo-
cation and to examine the effects of altering cAMP levels. apFRET results
show interactions between a-subunits with the highest FRET efficiency (Ef)
for C-terminally labeled KCNQ1 and hERG (12.0 5 5.2%), similar to intra-
tetramer FRET, only between labeled hERG a-subunits (11.95 5.9%). Acute
treatment for 5 or 30 min. with Forskolin (100mM) þ IBMX (100mM) signif-
icantly and specifically reduced Ef (7.15 7.2% and 7.95 4.3%, respectively,
P < 0.001). Cells expressing a FRET positive control (KCNQ1-CFP-YFP)
showed no change in Ef with treatment (21.4 5 5.1% vs. 20.8 5 5.6%,
P=0.6). This work demonstrates regulated interactions between the C- termini
of KCNQ1 and hERG, members of two distinct potassium channel families,
and future studies will determine whether direct binding of cAMP abrogates
KCNQ1-hERG interactions or if other downstream (PKA-mediated) processes
are involved.
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Evidence has emerged that KCNQ1 and HERG potassium channels can directly
interact when co-expressed in heterologous cells, but the reliance on double
transient transfection in these prior experiments confounds interpretation of
the resultant channel properties. We employed a new, highly stable HERG
cell line to revisit the biophysical and pharmacological properties of
KCNQ1-HERG currents. Whole-cell current was measured at the end of
a 2 s pulse from 80 to þ60 mV and at peak tail current (TC) recorded at
50 mV. The peak current for stable HERG cells at þ50 mV was 5.5 pA/pF
(þ50mV) and TC amplitude was 16.9 pA/pF with activation V½ of 9.351.9
mV (n=12). Transient transfection of stable HERG cells with KCNQ1 (0.3mg
cDNA) generated 14-fold greater current density measured at þ50 mV (76.6
pA/pF) and a 1.5-fold greater TC density (25.3 pA/pF) compared with
HERG alone. Compared to transient expression of KCNQ1 alone, current den-
sity in HERG-KCNQ1 cells was 2.8-fold and 28-fold greater at þ50 mV and
for peak TC, respectively. Gating kinetics more closely resembled KCNQ1
alone as did activation V½ values (HERG, 9.351.9 mV; KCNQ1,
14.551.9 mV; HERG-KCNQ1, 6.850.9 mV). Dofetilide (1mM) and
HMR-1556 (10mM) were used to dissect HERG-KCNQ1 current. KCNQ1 is
blocked by HMR-1556 (100% activation and 70% TC) but is dofetilide-
insensitive. HERG TC is blocked 90% by dofetilide but only 30% by HMR-
1556. HERG-KCNQ1 block was different: HMR-1556 reduced activation by
90% and TC by 70% and dofetilide blocked both activation (50%) and tail-
currents (70%). HMR-1556 sensitive and dofetilide sensitive current compo-
nents differed from KCNQ1 or HERG alone. Moreover, dofetilide sensitive
current exhibit distinct gating properties from either KCNQ1 or HERG. These
results demonstrate that co-expression of KCNQ1 and HERG yields current
with gating and pharmacological properties distinct from the two parent
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Plasma membrane (PM) phosphatidylinositol 4,5-bisphosphate (PI(4,5)P2) is
required for KCNQ2/3 channel activity. To determine precursor sources of
the plasma membrane (PM) PI(4,5)P2 pool in tsA-201 cells, we monitored
KCNQ tail currents and YFP-PH(PLC-delta) translocation as real-time indica-
tors of PM PI(4,5)P2, and GFP-OSH1-PH as an indicator of Golgi PI(4)P. We
selectively depleted PI(4)P pools at the PM, or the Golgi, or both using
rapamycin-translocatable enzymes, pseudojanin, an engineered tandem 4-
and 5-phosphatase (SAC1 and INPP5E). Selectively depleting PI(4)P at the
PM with pseudojanin-SAC (PJ-SAC; only SAC1 is active) results in a second-
ary decrease of PI(4,5)P2 measured by KCNQ channels or by PH-PLC do-
mains. Compared to control pseudojanin (PJ), the decrease in current with
PJ-SAC is only partial (~60% vs ~95%) and slower (140-s vs 14-s). Likewise,
translocation of PH-PLC is slower (61-s vs 20-s) than with control PJ and
smaller (~60% that of PJ). Depleting PI(4)P at the Golgi with PJ-SAC also in-
duces a secondary decline of PM PI(4,5)P2 measured by KCNQ channels. The
decrease is partial (35%), smaller than with PJ at the PM, and slower (60 s).
Depleting PI(4)P simultaneously at the Golgi and PM with PJ-SAC recruited
to both membranes also induces a slow secondary decrease of PI(4,5)P2 mea-
sured by KCNQ channels (100-s, 75%). Recruiting the ER towards the Golgi
using rapamycin-induced dimerization, mimics the effects of depleting PI(4)
P at the Golgi. In conclusion, the PM pool of PI(4,5)P2 depends on precursor
pools of PI(4)P both in the PM and in the Golgi. The decrease in PM PI(4,5)
P2 when SAC1 is active at the Golgi suggests that the Golgi contribution is
on-going and does not wait until the PM is depleted. (NIH grants NS08174,
GM83913 and RR025429).
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Phosphatidylinositol 4,5-bisphosphate (PI(4,5)P2) is an important regulator
of activity of a variety of ion channels including inwardly rectifying potassium
channels, KCNQ, TRP, and voltage-gated calcium channels. Several groups
have provided evidence that also voltage-gated potassium (Kv) channels might
be regulated by PI(4,5)P2. Taking the wide expression of Kv channels in a va-
riety of different tissues into account, such regulation of activity by PI(4,5)P2
could potentially be of great physiological importance. To determine whether
several Kv channels show a regulation of their activity by PI(4,5)P2 we have
coexpressed them in tsA201-cells with either a voltage-gated lipid 5-phospha-
tase (VSP), a G-protein coupled receptor (M1R), or an engineered fusion pro-
tein carrying both a 4- and 5-lipid phosphatase activity (Pseudojanin, PJ). These
tools deplete PI(4,5)P2 with application of depolarization, muscarinic agonists,
or rapamycin, respectively. We monitored PI(4,5)P2 amounts at the plasma
membrane by FRET with PH-probes from PLCd1 simultaneously with
whole-cell patch-clamp recordings. Activating VSP or PJ inhibited KCNQ2/
3 channel current leaving only about 5-10 % remaining current. Activation
of M1R inhibited KCNQ2/3 current a comparable amount. Thus the tools
used for our assays are working. We tested with them for potential regulation
of activity by PI(4,5)P2 of Kv1.1/Kvb1.1, Kv1.3, Kv1.4 and Kv1.5/Kvb1.3,
Kv3.4, Kv4.2, Kv4.3 (both with different KChIPs and DPP6-s) and HERG/
KCNE2. Interestingly, we found a substantial upregulation of current density
and a removal of inactivation for Kv1.1/Kvb1.1 and Kv3.4 upon activation
of M1R, but no changes in activity upon only activating VSP or PJ. All other
channels tested showed no alteration in activity in any of the assays we used. In
conclusion, ‘‘physiological’’ depletion of PI(4,5)P2 at the plasma membrane
does not seem to influence activity of most tested Kv channels. Supported by
NIH grant NS08174 and the AvH Foundation.
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Phosphatidylinositol 4,5-bisphosphate (PIP2) is an important regulator of ion
channel activity. While PIP2 modulation of voltage-independent Kir channels
has been extensively studied, the mechanism of how PIP2 potentiates the activ-
ity of voltage-dependent ion channels remains uknown. In this work, we study
